UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses

The Journal of clinical investigation, 2022-09, Vol.132 (17), p.1-10

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy

Translational research : the journal of laboratory and clinical medicine, 2013-04, Vol.161 (4), p.265-283

2013

Link zum Volltext

Verfügbarkeit prüfen

Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System ® (RTS ® ) gene switch as gene therapy for the treatment of glioma

Cancer gene therapy, 2018-06, Vol.25 (5-6), p.106-116

2018

Link zum Volltext

Verfügbarkeit prüfen

Third-party umbilical cord blood–derived regulatory T cells prevent xenogenic graft-versus-host disease

Cytotherapy (Oxford, England), 2014-01, Vol.16 (1), p.90-100

2014

Link zum Volltext

Verfügbarkeit prüfen

Antigen-independent and antigen-dependent methods to numerically expand CD19-specific CD8+ T cells

Experimental hematology, 2007-07, Vol.35 (7), p.1083-1090

2007

Link zum Volltext

Verfügbarkeit prüfen

Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial

Science translational medicine, 2019-08, Vol.11 (505)

2019

Link zum Volltext

Verfügbarkeit prüfen

Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors

Molecular therapy, 2016-07, Vol.24 (7), p.1178-1186

2016

Link zum Volltext

Verfügbarkeit prüfen

A Transposon and Transposase System for Human Application

Molecular therapy, 2010-04, Vol.18 (4), p.674-683

2010

Link zum Volltext

Verfügbarkeit prüfen

Amplification of RNAi—Targeting HLA mRNAs

Molecular therapy, 2005-05, Vol.11 (5), p.811-818

2005

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia

Human gene therapy, 2018-05, Vol.29 (5), p.602

2018

Link zum Volltext

Verfügbarkeit prüfen

Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System

Molecular therapy, 2016-06, Vol.24 (6), p.1078-1089

2016

Link zum Volltext

Verfügbarkeit prüfen

Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies

Human gene therapy, 2012-05, Vol.23 (5), p.444

2012

Link zum Volltext

Verfügbarkeit prüfen

CARs on Track in the Clinic

Molecular therapy, 2011-03, Vol.19 (3), p.432-438

2011

Link zum Volltext

Verfügbarkeit prüfen

Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy

Human gene therapy, 2013-10, Vol.24 (10), p.824

2013

Link zum Volltext

Verfügbarkeit prüfen

Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor

Journal of immunotherapy (1997), 2016-06, Vol.39 (5), p.205

2016

Link zum Volltext

Verfügbarkeit prüfen

Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanoma

Journal of immunotherapy (1997), 2014-11, Vol.37 (9), p.448

2014

Link zum Volltext

Verfügbarkeit prüfen

piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies

Human gene therapy, 2010-04, Vol.21 (4), p.427

2010

Link zum Volltext

Verfügbarkeit prüfen

Sleeping beauty system to redirect T-cell specificity for human applications

Journal of immunotherapy (1997), 2013-02, Vol.36 (2), p.112

2013

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide mapping of PiggyBac transposon integrations in primary human T cells

Journal of immunotherapy, 2009-10, Vol.32 (8), p.837-844

2009

Link zum Volltext

Verfügbarkeit prüfen

Universal artificial antigen presenting cells to selectively propagate T cells expressing chimeric antigen receptor independent of specificity

Journal of immunotherapy (1997), 2014-05, Vol.37 (4), p.204

2014

Link zum Volltext

Verfügbarkeit prüfen

Adoptive Immunotherapy of Disseminated Leukemia With TCR-transduced, CD8+ T Cells Expressing a Known Endogenous TCR

Molecular therapy, 2009-04, Vol.17 (4), p.742-749

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaResearch & Experimental Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(26)
Buchkapitel
(1)

Sprache

Englisch
(27)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Medicine, Research & Experimental
(27)
Science & Technology
(27)
Humans
(21)
Biotechnology & Applied Microbiology
(14)
Genetics & Heredity
(12)
Animals
(11)
Gene Therapy
(11)
Lymphocytes
(10)
T-Lymphocytes - Immunology
(9)
Cell Line, Tumor
(8)
Immunology
(8)
Mice
(8)
Oncology
(8)
Immunotherapy, Adoptive
(7)
Receptors, Antigen, T-Cell - Genetics
(7)
Antigens
(6)
Cytokines
(6)
Immunotherapy
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses

Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy

Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System ® (RTS ® ) gene switch as gene therapy for the treatment of glioma

Third-party umbilical cord blood–derived regulatory T cells prevent xenogenic graft-versus-host disease

Antigen-independent and antigen-dependent methods to numerically expand CD19-specific CD8+ T cells

Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors

A Transposon and Transposase System for Human Application

Amplification of RNAi—Targeting HLA mRNAs

Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia

Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System

Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies

CARs on Track in the Clinic

Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy

Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor

Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanoma

piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies

Sleeping beauty system to redirect T-cell specificity for human applications

Genome-wide mapping of PiggyBac transposon integrations in primary human T cells

Universal artificial antigen presenting cells to selectively propagate T cells expressing chimeric antigen receptor independent of specificity

Adoptive Immunotherapy of Disseminated Leukemia With TCR-transduced, CD8+ T Cells Expressing a Known Endogenous TCR

Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy

Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy

Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy

Aktive Filter

Suchergebnisse filtern